Core Viewpoint - The recent executive changes at China Bank Consumer Finance Co., Ltd. (中银消费金融) reflect a normal personnel adjustment aimed at enhancing the company's technological capabilities and online business operations [5][6]. Group 1: Executive Changes - The Shanghai Regulatory Bureau of the National Financial Supervisory Administration approved the appointment of Niu Xiaofeng as the Deputy General Manager of China Bank Consumer Finance [1]. - Niu Xiaofeng is required to report his onboarding status within 10 days after his appointment and must start his role within three months [1]. - This marks the second executive appointment for the company in 2023, with the first being He Weiwen as a director in March [6]. Group 2: Company Structure and Management - As of the end of 2024, China Bank Consumer Finance's senior management consists of six members, including one General Manager and three Deputy General Managers [5]. - The board comprises 11 directors, with recent changes including Gao Weibin replacing Zhu Qiangbiao as Chairman and Chen Xiaolin taking over from Tian Hongyan as Executive Director [5]. Group 3: Industry Context - The consumer finance industry has seen significant executive turnover, with at least 26 changes across 17 licensed consumer finance institutions in 2023 [6]. - The industry is undergoing a transformation from offline to online operations, increasing the importance of technology and online capabilities [5]. - The high turnover of executives is attributed to the challenges faced in technology development, scenario expansion, interest rate pricing, and non-performing asset management [6].

Core Insights - The company reported a revenue of 2.704 billion yuan in 2024, a year-on-year decline of 13.84%, and a net profit attributable to shareholders of 438 million yuan, down 7.3% year-on-year, while the non-net profit increased significantly by 1365.5% to 403 million yuan due to increased revenue and profit from the pharmaceutical industrial sector and a decrease in overall expenses [1] Group 1: Pharmaceutical Industrial Sector - The company's core products include cardiovascular drugs and respiratory disease medications, with higher demand observed in the first and fourth quarters due to seasonal factors [2] - In Q1 2024, there was a significant increase in the demand for respiratory disease medications due to a surge in viral flu cases, alongside a rise in cardiovascular drug demand during the spring [2] Group 2: Pharmaceutical Commercial Sector - The pharmaceutical commercial sector faced revenue impacts due to the increasing number and amount of products subject to national centralized procurement, leading to price reductions [3] - Hospitals are actively reducing procurement scales and amounts in response to ongoing medical reforms, resulting in decreased delivery orders for the company [3] Group 3: Traditional Chinese Medicine Trade Sector - The company anticipates a significant price correction in traditional Chinese medicine after a period of price increases, leading to a strategic reduction in non-productive trade activities to mitigate high-level risks [3] - In Q2, the company increased revenue by strategically selling part of its inventory of traditional Chinese medicine in anticipation of a price decline in the latter half of the year [3]

Core Viewpoint - The "2025 China Enterprises Going Global Summit" aims to provide a high-end platform for Chinese companies to address challenges and explore win-win transformation paths in the context of global industrial chain restructuring [1] Group 1: Forum Overview - The summit was held in Shenzhen on June 28-29, organized by Phoenix Network and supported by the Snow Beer brand, focusing on the theme "For an Open World" [1] - The event seeks to facilitate thought exchange, resource connection, and regulatory dialogue among Chinese enterprises [1] Group 2: Key Insights from Hu Jie - Hu Jie discussed the impact of the century-long changes and globalization 2.0, emphasizing that the industrial chain is transitioning from heavy manufacturing in China to "China + 1" and "China + N" models [2] - He noted that Chinese companies have strong competitive advantages but also face challenges, necessitating a focus on high-quality international expansion and soft power enhancement [2] - Companies should develop strategic planning capabilities and strengthen cross-cultural management to better understand global perspectives [2] Group 3: Challenges and Recommendations - Hu Jie highlighted the need for companies to avoid political and industry risks, particularly the threat posed by competition from other Chinese firms [3] - He emphasized the importance of ESG practices for companies going global, aligning with international standards [3] - The focus on brand development is crucial, as a strong brand can help companies establish a presence in foreign markets, requiring an understanding and respect for local cultures [3]

资料显示，乐高大飞车是乐高全球首发主题区的全球首发游玩项目之一，也被称为上海乐高乐园的镇园 之宝，是上海乐高乐园度假区最长的过山车，轨道总长530米。在此前5月31日-6月19日的内测期间，乐 高大飞车一直未对游客开放体验，直至6月20日转入试运营阶段后才开始接待游客。此前，5月28日，上 海乐高乐园度假区一日票及酒店销售正式开启，在首发达人直播间，不到半小时就售出门票近3000张。 21世纪经济报道记者 易佳颖 上海报道 不过，这不是上海乐高乐园试运营期间发生的第一起事故。6月20日，上海乐高乐园试运营首日，4D影 院在播放影片期间突然"倾盆大雨"。影院顶部喷水装置出现故障，喷水不停，不少观众被淋湿后疏散。 6月28日中午，正在试运营的上海乐高乐园，"乐高大飞车"卡住了。 "经初步排查，为水特效设备问题。"彼时，乐园运营方在媒体采访中回应，"试运营期间，上海乐高乐 园还将继续测试所有设备，及时发现并整改各类问题。对于本次水特效设备问题给参加试运营游客带来 的不良体验，上海乐高乐园表示歉意，并第一时间对现场游客予以解释道歉和安抚。" 从网上流传的照片和视频看到，"乐高大飞车"停在半空中，数十位游客坐在设备内。 ...

Group 1 - The Trade Desk (TTD) is recognized as a leading Demand Side Platform (DSP) within the digital advertising ecosystem, indicating its significant role in the industry [1] - Recent corrections from the 2024 highs may present a relative value buy opportunity for TTD, although it has historically been viewed as a premium growth investment [1] - The analysis emphasizes a focus on equity valuation, market trends, and portfolio optimization to identify high-growth investment opportunities [1] Group 2 - The analyst has over 20 years of experience in quantitative research, financial modeling, and risk management, highlighting a strong background in the financial sector [1] - The approach to investment research combines rigorous risk management with a long-term perspective on value creation, aiming to provide actionable insights for investors [1]

6月27日，全世界都在围观一场史上最贵的婚礼 —— 61岁的前世界首富，亚马逊创始人杰夫·贝索斯，与56岁的前电视主持人劳伦·桑切斯在意大利威尼斯 举办盛大婚礼。 这对年龄加起来110+的新婚夫妇在意大利威尼斯砸了个天价，办了一场让全球富豪都眼红的世纪大婚。 据说花费耗资4800万欧元（约合人民币4亿元），可谓吸引了全世界的目光。 亿万富豪杰夫·贝索斯与前妻离婚的同一年，便与前新闻主播桑切斯开启了感情的第二春，两人频频同出同入，十分高调。 11 1 11 0 两年前欧洲度假期间，杰夫·贝索斯更是送上一枚30克拉的订婚戒向这名艾美奖获奖记者求婚。 尽管外界对这段感情持怀疑态度，甚至不断传出分手的消息，但这对情侣已经携手走过了超过5年的时光，现在他们更是走进了婚姻的神圣殿堂。 二人共同出席戛纳红毯 而婚礼刚结束，桑切斯第一时间把社交账号名字加上了贝索斯的姓，还把前面的帖子都隐藏了。 以前的桑切斯不在了，现在重生的是贝索斯夫人 Call me Mrs.Bezos from now on！ 对于全球顶尖富豪而言，传统"豪华婚礼"已显不足，"超级婚礼"正成新常态。 咱们前世界首富贝索斯，为了这场老房子着火的爱情，可是一 ...

Performance Comparison - The Dividend Aristocrats experienced an average gain of 0.36% in June, significantly underperforming compared to the SPDR S&P 500 Trust ETF (SPY), which had a gain of 4.64% [1] Analyst Insights - The article is authored by an analyst with over 10 years of experience in the investment arena, indicating a strong background in financial analysis and investment strategies [1] Investment Focus - The analyst expresses a personal interest in dividend investing, suggesting a focus on companies that consistently increase their dividends, which may appeal to income-focused investors [1]

"G7无法单独做出决定"，任何提案都需要在OECD层面由147个成员批准。 当地时间6月28日，美国与七国集团（G7）其他成员国达成协议，豁免美国大型跨国企业缴纳更多海外 税款。 该声明称，将采用一种"并行"式的税收解决方案，允许美国跨国公司免于适用收入纳入规则（IIR）和 低税利润规则（UTPR）。作为交换条件，美国将在其"大而美法案"中删去备受争议的899条款，该条款 授权美国对实施"歧视性"税收政策的国家实施报复性加税。 G7在声明中称，这一方案将保留经合组织（OECD）/二十国集团（G20）包容性框架内各辖区在应对税 基侵蚀和利润转移（BEPS）方面取得的重要成果，同时为国际税收体系的未来发展提供更大的稳定性 和确定性。 然而，该协议若最终实施，将从根本上改变2021年达成的全球最低企业税改协议。诺贝尔经济学奖得 主、国际企业税收改革独立委员会联合主席斯蒂格利茨（Joseph Stiglitz）表示，G7协议表明各国政 府"将跨国公司的利益置于中小型企业、本国公民和全球普通人之上"。 OECD税务负责人科温（Manal Corwin）则表示，"G7无法单独作出决定"，该声明不具约束力，任何提 案都需要 ...

荣格个人护理 . 以下文章来源于荣格个人护理 ，作者荣格研讨会 MicroZenith@紫球藻提取物 抗皱,紧致,防晒,保湿、抗 氧化、抗菌、抗病毒 我司海洋微藻细胞培养的优势: 个人护理、美容、化妆品、香水、包装等行业专业人士必读，覆盖全球资讯，关注中国市场，荣格工业 传媒旗下《happi China 国际个人护理品生产商情》杂志，美国《happi》与《Beauty Packaging》杂志在 中国唯一合作伙伴。 在竞争激烈的美妆赛道中，美妆品牌如何走向差异化与高端化，这家微藻合成生物公司希望用新一代藻类提取物 （三角褐指藻提取物、紫球藻提取物、小球藻提取物）助力国产品牌走向高端化、国际化。 MicroZenith@小球藻提取物 抗皱,紧致,祛痘、舒缓、保 湿、抗氧化 1) 微藻活性物密度高5-10倍。海洋微藻一般难以采 用异养等高密度培养方法,但通过合成生物+光控培养 技术可以将微藻细胞密度和生物活性成分提高5-10倍。 2）微藻活性物高品质。传统的跑道池、管式反应器中 重金属或塑化剂的污染难以有效避免和控制，我司开 发了独家专利的新型生物反应器,有效解决污染问题。 3)无菌、无重金属、无农残,无核污染。 ...

项目进展 | 肆芃科技 【SynBioCon】 获 悉 ， 6月26日， 肆芃生物新材料(南通)有限公司 千吨级生物基产品生产线(1,3-PDO(1,3-丙二醇)、乳酸钙、 香兰素、唾液酸加工项目) 环境影响报告书受理公示。 肆 芃 生物新材料(南通)有限公司成立于2024年7月，是上海肆 芃 科技有限公司全资子公司，上海 肆 芃成立于2022年5月，是一家聚 焦于负碳合成生物学的新型科技公司，于2024年10月完成近亿元"Pre-A"轮融资，2025年5月完成数千万元"Pre-A+"轮融资。 千吨级生物基产品生产线项目 总投资 5000 万元 ，位于 如皋高新技术产业开发区如皋电子信息及泛半导体产业园(东区)， 项目建成后 将形成 年产 7 20吨1,3-丙二醇、940 吨乳酸钙、30 吨香兰素、10吨唾液酸的生产能力 。 | 产品名称 | 产品规 | 设计 产能 | | 批次产 | 来生 产批 | 生产 连续 | 产品包 装形式 | 产品用途 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 格 | ( t/a | 运行时间(h/a ...